Gilead Sciences
Price & Volume
Stats
See more52W Range | $86.59-$127.85 |
Market Cap | $149.7B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $29B |
Revenue Growth (YoY) | 3% |
Gross Profit (12 Mos) | $22.8B |
Diluted EPS | $6.46 |
News
See moreYahoo Finance • 10 days ago
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Yahoo Finance • 11 days ago
Stocks Fall Slightly in Thin Holiday Trade
Yahoo Finance • 11 days ago
Stocks Slip as Bond Yields Rise
Yahoo Finance • 11 days ago
U.S. stocks struggle as tech-led sell-off continues into the year's last days
About
CEO | Mr. Daniel P. O'Day |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,600 |
